|
2.7 Etiologie - Obésité
|
|
|
|
3.1 Tabac
|
|
|
Tobacco treaty has helped cut smoking rates, but more work needed [Reuters]
|
|
|
|
|
|
In
a study published in the Lancet Public Health journal, researchers from
Canada's University of Waterloo and the World Health Organization (WHO)
found that while progress against what they called the "global tobacco
epidemic" has been substantial, it has still fallen short of the pace
called for by the treaty.
|
|
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
Patients’ reports may aid prostate cancer treatment choice [STAT]
|
|
|
|
|
|
The
research bolsters evidence that sexual problems and urinary
incontinence are more common after surgery than after radiation or
“watchful waiting” without treatment. But it also shows differences in
quality of life tend to wane with time for those with prostate cancer
that hasn’t spread — the type that affects most men with the disease.
|
|
|
|
|
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
|
Pierre Fabre and H-Immune Announce Research Partnership to Develop Cancer Immunotherapies [Pierre Fabre]
|
|
|
|
|
|
As
a newly established bioscience company in the immuno-oncology field and
spin out from the French Atomic Energy Commission, H-Immune has
developed a proprietary In Vitro Immunization (IVI) technology
leveraging a breakthrough approach to generate a series of fully human
monoclonal antibodies (mAbs) against any therapeutic target, taking
advantage of the affinity maturation processes performed in situ by B
lymphocytes.
|
|
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
This is Not a Test: RMAT Designation Goes Live [FDA Voice]
|
|
|
|
|
|
Examples
include genetically-modified cellular therapies, such as chimeric
antigen receptor T-cells (CAR-T cells) and human tissues grown on
scaffolds for subsequent use. These products hold great promise in
addressing serious unmet medical needs. For example, data from a number
of different published studies indicate the potential for CAR-T cells to
treat certain relapsed or refractory blood cancers.
|
|
|
|
|
|
|
5.12.4 Immunothérapies - Essais
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
6.1 Observation
|
|
|
|
6.2 Implants mammaires
|
|
|
|
|
6.6 Publications
|
|
|
|
6.9 Controverses
|
|
|